Ramipril and Bile duct obstruction - a phase IV clinical study of FDA data
Bile duct obstruction is found among people who take Ramipril, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years.
The phase IV clinical study analyzes which people take Ramipril and have Bile duct obstruction. It is created by eHealthMe based on reports of 123,232 people who have side effects when taking Ramipril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
123,232 people reported to have side effects when taking Ramipril.
Among them, 22 people (0.02%) have Bile duct obstruction.
What is Ramipril?
Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 126,267 Ramipril users for its effectiveness, alternative drugs and more.
What is Bile duct obstruction?
Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder) is found to be associated with 1,190 drugs and 583 conditions by eHealthMe.
Number of Ramipril and Bile duct obstruction reports submitted per year:
Time on Ramipril when people have Bile duct obstruction *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 100 %
- 10+ years: 0.0 %
Gender of people who have Bile duct obstruction when taking Ramipril *:
- female: 54.55 %
- male: 45.45 %
Age of people who have Bile duct obstruction when taking Ramipril *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 22.22 %
- 50-59: 11.11 %
- 60+: 66.67 %
Common drugs people take besides Ramipril *:
- Lantus: 6 people, 27.27%
- Hydrochlorothiazide: 5 people, 22.73%
- Sandostatin Lar: 5 people, 22.73%
- Actos: 4 people, 18.18%
- Lexapro: 3 people, 13.64%
- Benicar: 3 people, 13.64%
- Rebif: 3 people, 13.64%
- Celebrex: 2 people, 9.09%
- Indocin: 2 people, 9.09%
- Effexor: 2 people, 9.09%
Common side effects people have besides Bile duct obstruction *:
- Hair Growth Abnormal: 5 people, 22.73%
- Thyroid Cancer: 5 people, 22.73%
- Hair Loss: 5 people, 22.73%
- Hair Disorder: 5 people, 22.73%
- Chest Pain: 4 people, 18.18%
- Choledocholithiasis (stones in the common bile duct): 3 people, 13.64%
- Biopsy Bile Duct Abnormal: 3 people, 13.64%
- Pancreatitis Acute (sudden inflammation of pancreas): 3 people, 13.64%
- Cerebral Thrombosis (blood clot in brain): 3 people, 13.64%
- Rectal Haemorrhage (bleeding from anus): 3 people, 13.64%
Common conditions people have *:
- Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 5 people, 22.73%
- High Blood Cholesterol: 4 people, 18.18%
- Depression: 4 people, 18.18%
- Diabetes: 3 people, 13.64%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 13.64%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.64%
- Sleep Disorder: 2 people, 9.09%
- Hypokalemia (low potassium): 2 people, 9.09%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Ramipril and have Bile duct obstruction?Check whether Bile duct obstruction is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Bile duct obstruction and when was it recovered:
Expand to all the drugs that have ingredients of ramipril:
Alternative drugs to, pros and cons of Ramipril:
- Ramipril (126,267 reports)
Common Ramipril side effects:
- Breathing difficulty: 8,099 reports
- Fatigue (feeling of tiredness): 7,681 reports
- High blood pressure: 6,811 reports
- Dizziness: 6,630 reports
- Diarrhea: 6,490 reports
- Hypotension (abnormally low blood pressure): 6,084 reports
- Weakness: 5,748 reports
Browse all side effects of Ramipril:a b c d e f g h i j k l m n o p q r s t u v w x y z
Bile duct obstruction treatments and more:
- Bile duct obstruction (3,331 reports)
COVID vaccines that are related to Bile duct obstruction:
- Bile duct obstruction in Moderna COVID Vaccine
- Bile duct obstruction in Pfizer BioNTech Covid Vaccine
- Bile duct obstruction in Johnson and Johnson Covid Vaccine
Common drugs associated with Bile duct obstruction:
- Prednisone: 268 reports
- Humira: 259 reports
- Sandostatin: 257 reports
- Sandostatin lar: 204 reports
- Omeprazole: 152 reports
- Methotrexate: 151 reports
- Aspirin: 151 reports
- Morphine: 122 reports
- Metformin: 104 reports
All the drugs that are associated with Bile duct obstruction:
- Bile duct obstruction (1,190 drugs)
Common conditions associated with Bile duct obstruction:
- Rheumatoid arthritis: 233 reports
- High blood pressure: 171 reports
- Type 2 diabetes: 131 reports
- Pain: 114 reports
- Multiple sclerosis: 111 reports
All the conditions that are associated with Bile duct obstruction:
- Bile duct obstruction (583 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ovcon-35 and Keloids - a second ago
- Stilnoct and Neck Pain - 6 seconds ago
- Singulair and Chapped Lips - 13 seconds ago
- Adderall 5 and Hypothyroidism - 14 seconds ago
- Fluphenazine vs. Thorazine - 17 seconds ago
- Flovent and Osteoarthritis - 17 seconds ago
- Clonazepam and Saphris drug interaction - 19 seconds ago
- Betamethasone Valerate and Depressed Level Of Consciousness - 21 seconds ago
- Ortho Tri-Cyclen Lo vs. Loestrin 21 1/20 - 21 seconds ago
- Xolair and Pseudotumor Cerebri - 23 seconds ago